Elektrofi
Aditya K. is a skilled scientist specializing in analytical development and characterization of drug products, currently serving as Scientist I and Senior Associate Scientist at Elektrofi since July 2021. Expertise includes the development of robust analytical methods utilizing various microscopy techniques and optimization of drug formulations for commercialization. Prior experience includes contributions at Voyager Therapeutics, Inc. in analytical tech operations and acute analysis of adeno-associated viruses, as well as significant roles at Vertex Pharmaceuticals focusing on analytical method development for drug screening. Aditya began an academic journey at Northeastern University, earning a Bachelor's degree in Biology, alongside early research experience at The Chinese University of Hong Kong in stem cell tissue engineering.
This person is not in any teams
Elektrofi
1 followers
Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company’s founding team of MIT engineers and scientists are shaping the future of biologics delivery.